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ABSTRACT: Neuronal R-type Ca 2+ channels (Cav2.3) are expressed at high concentrations within 
the cortex, hippocampus and striatal regions of the brain, where they participate in neuronal 
excitability and synaptic signaling. This pattern of expression may signify a connection between 
Cav2.3 channel function and neurological disorders such as Parkinson's Disease (PD) and 
Huntington's Disease (HD). Both of these disorders are caused by inadequate secretion of the 
neurotransmitter dopamine within the striatum. The first step in characterizing the potential 
importance of Ca v2.3 in PD and HD is to examine its modulation by G-protein-coupled dopamine 
receptors. Specifically, we aim to characterize modulation of Cav2.3 by dopamine 1 (01) and 
dopamine 2 (D2) receptors functioning as obligate heterodimers. The initial phase of the project 
involves the construction, using molecular biological techniques, of mutant Dl and D2 receptors 
that will form obligate heterodimers. The project will culminate with expression of the obligate 
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INTRODUCTION 
Cav2.3 is a voltage-dependent, neuronal R-type calcium channel. Voltage-dependent 
calcium channels play an essential role in the regulation of many cellular functions, to include but 
not limited to membrane excitability, synaptic transmission, and exocytosis. Researchers only 
recognized four distinct types of calcium channel (T-, L-, N-, and P-type) before the 1992 discovery 
of the R-type calcium channel [11]. Channel types are distinguished from one another based on 
their electrophysiological and pharmacological properties [11]. R-type calcium channels were 
initially identified in rabbit brain tissue samples, and were demonstrated to have the same general 
structural features and membrane topology that the other voltage-gated calcium channels possessed 
[ 11]. R-type Ca 2• channels are resistant to most of the specific blockers of the other calcium 
channel types. 
C av2.3 channels are heavily expressed within the cortex, hippocampus, and the striatal 
regions of the brain . This channel appears to play a special role in the dendritic spines of neurons 
within these areas. Dendritic spines are specialized sub-cellular structures that form synapses with 
other neurons. This area of concentrated expression is particularly interesting because it could 
mean that the Ca v2,3 channel has major implications in medicine. It is highly relevant to 
understanding the molecular basis for neurological disorders such as Huntington's Disease and 
Parkin son's Disease. 
Abnormalities in dopaminergic signaling pathways have been linked to both Parkinson's 
Disease (PD) and Huntington's Disease (HD). Parkinson's is characterized by a loss of 
dopaminergic neurons within the substantia nigra. These neurons normally project their axons 
into the striatum, where they secrete dopamine. The neuronal death seen in PD will lead to a 
deficiency in dopaminergic signaling within the striatum, that will in turn lead to malfunction of 
7 
the striatum. This malfunction will result in a loss of coordinated movement of the body. HD is 
characterized by a severe loss of medium spiny neurons within the striatum. There is still a good 
deal of uncertainty surrounding the underlying cause of the neuronal loss in this hereditary 
disease; however, a mutation in the Huntingtin protein is thought to trigger the disease [1, 4, 6, 7, 
13]. 
The exact roles of Cav2.3 in the brain, especially within the previously defined areas of 
high concentration, remain incompletely defined. It has been proposed that these channels are 
modulated by G protein-coupled receptors, however the mechanisms behind this type of 
modulation remain relatively unstudied. This study plans to characterize the modulation of 
Cav2.3 by G protein-coupled dopamine receptors. Previous studies have noted that certain 
dopamine receptor complexes, especially heterodimeric complexes, are linked to an increase in 
intracellular calcium release and therefore to a possible increase in Cav2.3 functionality [12]. In 
this project, channel modulation will be observed with dopamine 1 (DlR) receptors functioning as 
homodimers, dopamine 2 (D2R) receptors functioning as homodimers, and then finally with 
Dl/D2 receptors functioning as obligate heterodimers. 
The first major step in the project is to induce the Dl/D2 receptors to function as obligate 
heterodimers. DlR and D2R are both categorized as G protein-coupled receptors (GPCR). The 
GPCR family is the largest family of mammalian genes known to date and plays an important role 
in many physiological and pathological pathways [2, 14]. GPCRs are activated by a wide range of 
ligands through a series of distinctive conformational changes between their seven transmembrane 
segments (TM 1 - TM7) [2]. Once activated, GPCR activity can be changed through receptor 
dimerization. Dopamine GPCRs are typically found as functioning homodimers, especially within 
experimental protocols. Dopamine GPCRs can be experimentally modified to take up a 
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heterodim er form ation th rough th e additi on , using techniqu es of molecular clonin g, of a GABA 
recept or G terminal end [2]. Such manipul ations are made through careful crosschecks of th e G 
terminal domains of each dopamin e and GABA receptor subunit 's DNA sequ ence to ensure 
comp atibility . In order to characterize th e modul ation of Ca V2 .3 by heterodim er dopamin e 
receptors, it was imp ort ant to increase th e occurr ence of heterodim erization . Th e additi on of a 
GABA receptor G termin al end to dopamin e GPC Rs will moreover functi on as a qu ality control 
checkp oint of sort s th rough a intr acellular retenti on signaling pathway [2, 9]. 
Replacing th e D IR and D2 R receptor G termin al end s with th e G terminal end s of GABA 
Bl and GABA B2 receptors, respectively, will introdu ce an intrac ellular retenti on signal in th e 
form of a RSR amin o acid sequ ence [10]. Thi s signal codes for th e prot ein to be held within th e 
cell's end oplasmic reticulum (ER) and eventu ally to be degraded . Thi s retenti on signal can be 
bypassed, or masked, th rough th e form ation of a coiled-coil protein domain [2). Thi s sort of 
domain is achieved with a GABA B 1 and GABA B2 G termin al int eraction [8). Wh en th e 
chim eric dopa min e GPC Rs form d imers, wheth er th ey beco me homodim ers or heterodim ers, th eir 
newly att ached GABA G termin al end s will be brought into close enough proximity to int eract. 
However, dopamin e homodimers would not have th e pro per GABA receptor G termin al 
int eractions to create th e pro tein domain necessary for maskin g th e retenti on signal. D IR /G ABA 
Bl chim eric homodim ers would lack a C-termin al GABA B2 int eraction while D2 R/G ABA B2 
chim eric homodim ers would lack an int eraction with th e GABA Bl G termin al end . DIR and 
D2R heterodimeri c int eractions are th e only dim erization patt ern s within thi s prot ocol th at would 
allow for th e coiled-coil prot ein to form and mask th e retention signal so that the receptor can 
move from the ER to th e cell's plasma membran e. Thu s the heterodimeric dopamine receptor 
(D 1 R-D2R) will be expr essed on th e cell's plasma membran e without th e presence of homodim ers. 
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This project focused on constructing the DlR/GABA Bl chimeric receptor using 
molecular biological techniques. The 02R/GABA B2 chimeric receptor will be created in follow-
up procedures with both chimeric receptors eventually being expressed in a human embryonic 
kidney cell line (HEK) along with the Cav2.3 channel for patch-clamp analysis. 
METHODS 
The complementary DNAs (cDNAs) for the wild type DlR and 02R receptors were 
amplified and purified prior to this experimental protocol. The procedure to create the 
heterodimer started with examining the receptor cDNAs (DlR, GABA Bl, 02R, and GABA B2) 
to find appropriate primer locations. Previously published literature within the field of molecular 
biology has described each receptor in detail, to include their coding sequences and 
transmembrane domains (TMD). DlR is a receptor that is 1,340 base pairs in length and like 
most dopamine GPCRs it has seven TMDs [5, 15]. The primers for this cDNA segment were 
designed to flank the start of the coding sequence and the end of TMD seven. With this splice, 
the amplified DlR segment would lack a Gterminal end and would have a total length of 1010 
base pairs. 02R is a receptor that is 1,331 base pairs in length [3 ]. The primers for this segment 
were designed to flank the same regions as the DlR primers. The amplified D2R segment would 
also lack a Gterminal end and would have a total length of 1,284 base pairs. Primers for the 
GABA Bl and GABA B2 cDNA sequences were designed to only incorporate the last 600 base 
pairs within each receptor's coding sequence. This splice region includes only the Gterminal ends, 
and ER retention signals, of the GABA receptors. 
Th e prim ers were constru cted to allow for dir ectional clonin g. Each prim er was designed 
to be around 20 nucl eotide s in length and within a 40 to 60 percent guanin e/c ytosine nucleotid e 
ratio in ord er to incr ease th e likelihood of app ropri ate ann ealin g. Th e DIR and GABA Bl 
prim ers as well as the D2R and GABA B2 prim ers were designed to have meltin g temperatur es 
within th e same respective range. Restri ction enzyme (RE) cut sites for Kpnl , Xhol, BamHI , and 
EcoRI were engin eered int o th e prim ers in a way th at specified whi ch dir ection th e amplifi ed DNA 
segment s would fit togeth er and place th emselves int o th e pcDNA3.l(+) vector. Th e Multipl e 
C lonin g Site (MCS) within thi s vector cont ained th e restr iction sites selected for th e receptor 
sequ ences [FIG. l] . Th e REs selected were doubl e checked to ensur e th at th e clonin g sites did n ot 
exist within th e receptor insert sequences. Thu s th e thr ee prim ers used for th e D IR /G ABA Bl 
chim era (Kpnl, Xhol , and BamHI) would not cut within eith er of th e sequ ences; th ey would only 
cut at th e sites within th e MCS and th e sites engineered int o th e prim ers. 
pcDNA3.1 (+/-) 
5428/5427 hp 
FIGURE 1: The MCS within pcDNA3 .1(+) contain s RE sites for 
Kpnl and BarnHI. A double digest using Kpnl and BarnHI 
allowed for directional cloning to take place. The pcDNAJ .1(+) 
vector contains a gene for ampicillin resistance. 
The focus of th e expe rim ent al pro toco l 
narrowed at thi s po int to focus only on th e 
D lR and GABA Bl insert seq uences. Th e 
cDNA encodin g each recep tor needed to be 
amplified in a mann er th at wou ld incorpo rate 
th e RE sites includ ed within th e prim er 
sequences. Thi s amplifi cation occurr ed 
th rough a two-step Polymerase Ch ain 
Reaction (PC R) prot ocol. Because of th e 
relatively high meltin g point s (TM) of th e 
prim ers, th e ann ealing and extension ph ases th at are typically used durin g PCR were combin ed in 
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order to better accommodate the Q5 polymerase (New England Biolabs) selected for the 
reactions. The Q5 PCR Master Mix contained an enzyme appropriate buffer, dNTPs, and the 
polymerase. PCR grade water, forward and reverse primers, as well as template DNA for the DIR 
and GABA Bl receptors were added to the master mix. Reaction temperatures were set to 98°C 
for the initial and cyclic denaturation phases, and 72°C for the annealing and extension. Each 
receptor sequence reaction and a receptor specific control reaction (containing the respective 
receptor-specific primers, but no template DNA) cycled through the two-stage protocol 35 times. 
After the genes had been amplified, agarose electrophoresis gels containing the PCR products were 
run to ensure that the PCR products were an appropriate length against a 1kb Quick Load DNA 
Ladder [FIG. 4 and FIG. 5]. 
Ethidium bromide was included in the agarose gels to enable product visualization. Each 
amplimer that was seen under UV illumination was excised from the agarose gel and stored. The 
bands were then purified using a GFX PCR DNA and Gel Band Purification kit. The series of 
buffers and wash solutions that are used through out this procedure cleaned the DlR and GABA 
Bl receptor inserts for their subsequent RE double digests. 
The DlR receptor amplification product included cut sites for the KpnI enzyme at its 5' 
end and the XhoI enzyme at its 3' end [FIG. 2]. This XhoI site will anneal with the Xhol site 
engineered into the GABA Bl insert's 5' end [FIG. 2 and FIG. 3]. The 3' end of the GABA Bl 
insert contains the RE site for BamHI [FIG.3]. Both Kpnl and BamHI will anneal with 
complementary sites within the pcDNA3.l(+) plasmid MCS [FIG. 1]. This means that once ligated, 
the inserts and plasmid will ligate together in a directional fashion. Following digestion with the 
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appropriate REs, the DlR and GABA Bl inserts were both purified using th e GFX purification kit 
and stored at -20°C. 
Thi s protoc ol utilized the pcDNA3.l(+) vector for insertion of the chimeric GPCR cDNA. 
pcONA 3.1(+) has been designed for high-level and stable expression in mammalian cell lines as 
well as expression within competent E.coU bacterium [FIG . 1]. Its multiple cloning site (MCS) is 
available in two orientations both the forward ( +) and negative (-) direction s, which allows for 
greater flexibility when deciding on cloning orientation. Th e MCS within pcONA3.l(+) contains 
RE sites for Kpnl and BamHI. A double digest using Kpnl and BamHI allowed for directional 
cloning to take place [FIG . 6]. 
In a typical molecular biological protocols, dephosphorylation of the cloning vector would 
have followed th e pcONA3.l(+) double digest. Oephosphorylation is a practice that help s to 
increa se molecu lar cloning efficiency. Rem oving phosphate group s from the 5' cut edges of th e 
vector DNA removes th e capability of th e vector to self-ligate. Thi s particular protocol did not 
DlR Primer 
- Forward: GC GAG GGT ACC ACC ATG AGG ACT CTG AAC ACC TCT GCC 
- Kpnl - TM: 6S°C G/C: 60% 
- Reverse: AA AAA CTC GAG GGC ATT ATT CGT CGC AGG GCA AAG TCT GTA GC 
- Xhol - TM: 66°C G/C: 49% 
FIGURE 2: The DIR forward and rever se primers were designed to flank the beginning of the DIR coding sequence and the 
end of the seventh TMD. The red nucleotides in both primers are the bases that anneal to the template. The blue nucleotides 
represent the RE sites within the primers . Each site is palindromic and allows for the formation of sticky ends. The green ACC 
sequence is a Kozac sequence that will help polymerase enzymes to recognize the ATG start codon. 
GABA Bl Primer 
- Forward: AA AAA ere GAG CGC AGG CTG ATC ACC CGA GG 
- Xhol - TM: 72°C G/C: 60% 
- Reverse: AA AAA GGA TCC TCA err ATA AAG CAA ATG CAC TCG ACT CCC ATC AC 
- BamHI - TM: 71°C G/C: 41% 
FIGURE 3: The GABA Bl forward and reverse primers were designed to flank GABA Bl at the end of the seventh TMD 
coding sequence and the end of the Cterminus . The red nucleotides in both primers are the bases that anneal to the template. 
The blue nucleotides represent the RE sites within the primers. Each site is palindromic and allows for the formation of sticky 
ends. 
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require the use of a phosphatase because of th e sticky ends created with the vector RE double 
digest. The Kpnl and BamHI sticky ends would not be complementary and thus would not anneal 
to each other; pcDNA3.1(+) would not be able to self-ligate. 
In order to ligate the cut DlR and GABA Bl inserts to each other, as well as into the MCS 
of pcDNA3.1(+) cloning vector, a ligation reaction utilizing T7 DNA ligase (New England Biolabs) 
was performed. The amount of vector and insert DNA that had been cut and purified had to be 
estimated in order to achieve a 1:2:3 molar ratio of pcDNA3.1(+) to the DlR and GABA Bl 
inserts, respectively. Such calculations were performed based upon estimations of band intensity 
from electrophoresis gels of the PCR products. The ligation mixture that resulted was immediately 
applied to chemically competent bacteria to encourage DNA uptake and bacterial transformation. 
Transformation is the genetic alteration of a cell caused by the uptake of foreign DNA. Separate 
aliquots of E. coli One Shot TOP-10 bacteria were exposed to a ligation control or to the 
experimental ligation reaction. The control ligation consisted of cut pcDNA3.1(+) vector that was 
treated with ligase but no insert cDNAs in order to ensure that the vector was efficiently cut during 
the double digest. If uncut vector were to be present in the control ligation transformed E. coli, it 
would result in colonies that express vector but which lack the inserts. 
The chemically competent bacteria cells underwent a heat shock to begin the process of 
transformation. The cells were then incubated overnight at 37°C in a shaking incubator. The 
vector contains an AMP antibiotic resistance gene, which selected for only the bacteria cells that 
took up a plasmid. The cell cultures were grown on an AMP-containing agar that only allowed 
cells expressing the AMP-resistance gene to multiply. If the proper incubation had not been 
allowed, even the cells that have taken up the plasmid would not been capable of surviving on the 
14 
agar because they would not have had enough time to produce the amount of antibiotic resistance 
protein necessary for surv ival. 
RESULTS 
The PCR procedure utilizin g QS polymerase was successfu l in amp lifying th e DlR and 
GABAB Bl fragment sequences. After the cDNA sequences had been amp lified, agarose 
electrophoresis gels containin g the PCR products were run to ensure th at the PCR products were 
an appropriate length against a 1kb Quick Load DNA Ladder [FIG. 4 and FIG. 5]. The DlR 
fragment ran th e same distance as the 1.0 kilobase ladd er band; this is consistent with the 1,010 
base pair length calcu lated for the DlR fragment during splice site examination and primer design. 
The intensity of the DlR bands produced was estimated to be consistent with about two 
micrograms (2 µg) of DNA [FIG 4]. This concentra tion was reduced to about 1.0 µg during the 




FIGURE 4: The DIR PCR product was pipetted into lanes 3 and 4 of the agarose gel. A control PCR reaction, containing no 
template DIR DNA, was pipetted into lane 6. The control reaction was used to differentiate between DIR PCR product and 
background primer dimer interactions. The resulting gel (shown above) shows the DIR product and allowed for estimation of 





FIGURE 5: The GABA Bl PCR product was pipetted into lanes 3 and 4 of the agarose gel. A control PCR reaction , 
containing no template GABA B 1 DNA, was pipetted into lane 6 and lane 7. The control reaction was used to differentiate 
between GABA Bl PCR product and background primer dimer interactions. The resulting gel (shown above) shows the 
GABA Bl product and allowed for estimation of both the leng th and concentration of the insert bands. 
The GABA B 1 fragment ran faster than the 1.0 kilo base ladder band, which was consistent 
with the expected fragment length of 600 base pairs [FIG. 5]. The intensity of the two GABA Bl 
gel bands was estimated to be consistent with about 1.0 µg of DNA, total. This concentration was 
reduced to about 0.8 µg during the GFX purification of the bands. 
RE digests were performed on each of the purified inserts. Because of the estimated 
concentration of the bands, the RE double digest protocols were able to utilize the entirety of the 
each purified band. The concentrations of insert DNA after the double digests and following 
purification decreased to 80 percent of the previously estimated concentrations (0.8 µg of DlR 
and 0.64 µg of GABA Bl) . The pcDNA3.1(+) vector was also put throu gh a RE double digest and 
purification [FIG. 6] and was estimated to have a concentration of about 1.0 µg. These 





FIGURE 6: The double-dige sted pcDNA3 .1(+) was pipetted into lane s 3 and 4 of the agarose gel. A control, uncut 
pcDNA3 .1(+) vector, was pipetted into lane 6. The control was used to ensure that the cut vector was running linearly. Uncut 
pcDNAJ.1(+ ) ran on th e gel in a circular, and sup ercoiled, configuration . Supercoiled vectors will run faster on gels than linear 
DNA . The resultin g gel (shown above) shows the RE double digest pcDNA3 .1(+) product and allowed for estimation of 
concentration. 
The numb ers of moles found within each volume of recep tor insert DNA and vector DNA 
was calcu lated from the previou sly estimated conce nt rations. Th e DlR insert , after PCR and a RE 
double digest, was calcu lated to have 1.40 picomoles of DN A per 50 pl volume. Th e GABA Bl 
insert was calcu lated to have 3.85 picomo les of DNA per 50 pl volum e while th e cut pcDNA3.1(+) 
was calcu lated to have 0.28 picomoles of DN A per 50 pl volum e. Th ese molariti es were used to set 
up th e 1:2:3 molar ratio of pcDNA3.1(+) to th e DlR and GABA Bl inserts, respectively, within 
the T7 ligase protocol. 
Th e ligation and tran sform ation protocols were followed as described, yet ther e were no E. 
coli bacteria coloni es that grew on the AMP plat es. Th e ligation and tr ansformation steps within 
thi s protocol were perform ed again in order to troubl eshoot. The entire ligation reaction was 
added to the tran sformation reaction because it was thou ght that perhap s there was too little DNA 
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exposed to the bacteria. If the bacteria did not have access to enough vector DNA then the 
percentage of bacterial uptake would be dramatically decreased. 
DISCUSSION 
Since the bacterial tran sformation did not grow, the DIR/GABA Bl chimera receptor was 
not amplified to a point that a mini-prep protocol could be followed and ultimate purification 
cou ld be achieved. The ligation and transformation reactions performed need to be examined to 
ensure that their protocols are not the reason for the lack of bacterial growth. A suggestion for 
possible ligation success would involve increasing the amount of DNA within the reaction by two-
fold. The initial ligation reaction, after further review, seemed to have a smaller amount of DNA 
than recommended for bacterial transformation. 
Once the ligation and transformation protocols produce viable bacterial colonies the 
experimental protocol can precede on to final DIR/GABA Bl chimera receptor purification. The 
colonies that grow after a daylong incubation from ligation-transformed bacteria will be selected 
and inoculated into mini-cultures. After growth overnight at 37°C, individual mini-cultures will 
undergo a mini-prep procedure in order to begin to purify the DIR/GABA Bl chimera insert. A 
Sigma GenE lut e alkaline lysis mini-prep kit will be used. The purpose of the alkaline lysis protocol 
is to purify the vector DNA containing the insert from the E. coli cells in which it had been 
amplified. Alkaline Lysis calls for three solutions that all have different functions within the 
protocol: Solution I, Solution II, and Solution Ill. Solution I contains glucose, Tri s, and EDTA; it 
is used to resuspend the cell pellet after the first centrifugation. The glucose in the soluti on will 
keep th e cells at an optima l osmotic pressure so that the cells will not burst. The Tris buffer is 
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used to maint ain constant pH whil e th e EDT A chelates metal cations (this will destabilize th e cell 
membr anes and will deactivat e any DN ases in th e soluti on) . Soluti on II cont ains SDS (sodium 
dodecyl sulfat e) and NaO H . SDS denatur es most of th e proteins in th e sampl e and solubilizes th e 
cell membr anes. N aO H helpes to break down th e bacterial cell walls and denatur e any double 
strand ed DNA in th e sampl e. Thi s means th at both bact erial chrom osomal and vector DNA will 
become single str and ed . Soluti on Ill cont ains acetic acid and potassium acetate. Acetic Acid 
neutraliz es th e pH of th e reaction and thu s allows th e DNA to renatur e; however, only th e plasmid 
DNA , cont ainin g th e chim eric insert, will renatur e as it never fully separated to begin with because 
of its circular natur e. Th e potassium acetate precipitates SDS and chromosomal DNA from th e 
sampl e as well as any cellular debri s. Th e plasmid DNA cont ainin g th e D IR/ GABA Bl chim era 
will be elut ed and stored . 
To confirm th at th e colonies are expressing th e clone of int erest , and thu s th at th e mini-
prep DNA was in fact th e plasmid and chim eric insert s, a restr iction enzyme digest using Kpnl and 
BamHI will be perform ed to cut th e insert out of th e plasmid. Th e double digest pro du ct will be 
run on a gel and checked against a 1kb Qui ck Load DNA Ladd er for proper length . Ge l band s 
th at pass thi s fin al step with a total length th at combin ed th e D IR receptor and G termin al GABA 
Bl receptor will be sequ enced in th eir entir ety to confirm th e absence of unint end ed mutati ons. 
Th e D IR /G ABA Bl receptor DNA sequ ences will th en be stored in a -20°C freezer until th ey are 
needed for patch clampin g prot oco ls with th e Ca V2.3 chann el. 
Thi s research will provide fund ament al new inform ation regardin g dopamin e-depend ent 
modul ation of Ca V2 .3. Onc e th e striat al signaling pathw ays that modulate Ca V2.3 are bett er 
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und erstood , physicians will have a better und erstandin g of th e molecular physiology of th e brain 
and may be able to utili ze Ca V2.3 as a th erapeuti c target for neurol ogical diseases. 
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